(Q40409379)

20 September 2017

A T7 Endonuclease I Assay to Detect Talen-Mediated Targeted Mutation of HBV cccDNA. (English)

1 reference

20 September 2017

Kristie Bloom

1

1 reference

20 September 2017

Abdullah Ely

series ordinal

2

1 reference

20 September 2017

Patrick Arbuthnot

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2017

1 reference

Methods in Molecular Biology

20 September 2017

1 reference

20 September 2017

1540

1 reference

20 September 2017

85-95

1 reference

Genome engineering with targetable nucleases

20 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Sources of DNA double-strand breaks and models of recombinational DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Targeted DNA mutagenesis for the cure of chronic viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Control of cccDNA function in hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Antiviral therapy of chronic hepatitis B: can we clear the virus and prevent drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

A rapid and general assay for monitoring endogenous gene modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Transient cold shock enhances zinc-finger nuclease-mediated gene disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

FLASH assembly of TALENs for high-throughput genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6700-1_8

10.1007/978-1-4939-6700-1_8

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference